glp 1/ Who Should Explore GLP-1 Shots from BodyLogicMD? and intra GLP-1 Medications – Community Education
Description
What is new are these longer-acting formulations with monthly or quarterly injections
This will have a significant impact on traditional weight loss products which are struggling to compete
M.BaigA
Semaglutide's patent is set to expire in 2026
Physical therapists must update medical history forms to include specific questions about GLP-1 agonist use, and confirm that the patient has obtained the referral from a licensed provider and filled the prescription at a reputable source
For the first time ever, Medicare will cover GLP-1 medications specifically for weight loss, not just for diabetes or other conditions
